Pfizer posts Quarter 4 profit
Due to lower research expenses and higher demand for COVID-19 products than Pfizer had anticipated, the company unexpectedly posted a quarterly profit on Tuesday. Pfizer (NYSE: PFE) beat the analyst estimate of $-0.18 by $0.28 to report fourth-quarter EPS of $0.10. Contrary to the consensus estimate of $14.22 billion, revenue for the quarter came in …